...
首页> 外文期刊>American Journal of PharmTech Research >Design, Optimization and In Vivo Evaluation of Granisetron HCl Mouth Dissolving Films
【24h】

Design, Optimization and In Vivo Evaluation of Granisetron HCl Mouth Dissolving Films

机译:Granisetron HCl口溶膜的设计,优化及体内评价

获取原文
           

摘要

ABSTRACT Present work aimed at preparing quick onset of action of Granisetron HCl which is beneficial in emesis, aiding in the enhancement of bioavailability and is very convenient for administration without the problem of swallowing and using water. The films were prepared by using different grades of HPMC E3, E6 and E15, maltodextrin DE6 and other polymers by solvent casting method. They were evaluated for physical characteristics such as thickness, uniformity of weight, folding endurance, drug content, surface pH, percentage elongation and tensile strength and results were found to be satisfactory. The formulations were subjected to disintegration and in-vitro drug release test. The in vitro disintegration time of the optimized formulation F9 was 9 sec and drug release was found to be very fast i.e. 97.8% of within 8 min when compared with innovator product i.e 70.8%. In vivo studies confirmed that their potential as an innovative dosage form to improve the bioavailability and considered to be potentially useful for the treatment of emesis where quick onset of action is desirable. DSC and FTIR data revealed that no interactions takes place between the drug and polymers used in the optimized formulation. From the above results, it can be a good alternative to conventional Granisetron Hydrochloride tablets in the treatment of emesis. In vitro and in vivo evaluation of the films confirmed their potential as an innovative dosage form to improve delivery and quick onset of action of Granisetron Hydrochloride. Keywords: Granisetron Hydrochloride, fast dissolving oral films, emesis, HPMC, bioavailability studies.
机译:摘要目前的工作旨在使Granisetron HCl的作用迅速起效,这对呕吐有益,有助于提高生物利用度,并且非常易于服用,没有吞咽和用水的问题。通过溶剂流延法,使用不同等级的HPMC E3,E6和E15,麦芽糖糊精DE6和其他聚合物制备薄膜。对它们的物理特性进行了评估,例如厚度,重量均匀性,耐折性,药物含量,表面pH,伸长率和拉伸强度,结果令人满意。将制剂进行崩解和体外药物释放测试。优化制剂F9的体外崩解时间为9秒,与创新产品(即70.8%)相比,药物释放非常快,即8分钟内的释放率为97.8%。体内研究证实了它们作为改善生物利用度的创新剂型的潜力,并被认为对于希望快速起效的呕吐治疗具有潜在的作用。 DSC和FTIR数据表明,药物与优化配方中使用的聚合物之间没有相互作用。从以上结果来看,它可以作为常规的盐酸格拉尼司琼片治疗呕吐的良好选择。膜的体外和体内评估证实了其作为创新剂型的潜力,可改善盐酸Granisetron的递送和起效。关键字:盐酸Granisetron,快速溶解口腔膜,呕吐,HPMC,生物利用度研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号